İrfan Koca

9PUBLICATIONS
27CO-AUTHORS
Biologically active moleculesMolecular targetsCheminformatics and quantitative structure-activity relationshipsCharacterisation of biological macromoleculesChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 06, 2026
Novel Benzimidazole-Urea Phenylalanine Hybrids as Dual-Acting Antimicrobial and Anticancer Agents: In Silico and Biological Evaluation.

Tuğçe Deniz Karaca, İrfan Çapan, Yusuf Sert

|Nov 27, 2025
Anticancer and Immunomodulatory Effects of a Thiazolyl Benzodiazepine Targeting HSP90 in ER+ Breast Cancer.

Kubra Acikalin Coskun, Lutfi Tutar, Kezban Uçar Çifci

|May 21, 2024
Synthesis and biological studies of pyrimidine derivatives targeting metabolic enzymes.

Elif Korkusuz, Yusuf Sert, Seher Arslan

|Dec 17, 2023
Deciphering the Biophysical Properties of Ion Channel Gating Pores by Coumarin-Benzodiazepine Hybrid Derivatives: Selective AMPA Receptor Antagonists.

Mohammad Qneibi, Mohammed Hawash, Mehmet Gümüş

|Feb 24, 2023
Triad pyrazole-thiazole-coumarin heterocyclic core effectively inhibit HSP and drive cancer cells to apoptosis.

Mehmet Gümüş, İrfan Koca, Yusuf Sert

|Feb 08, 2022
Synthesis, molecular docking, molecular dynamics and evaluation of Drug-Likeness properties of the fused N-Formyl pyrazoline substituted new dehydroepiandrosterone derivatives.

İrfan Çapan, Abdulmalik Shehu, Yusuf Sert

Pageof 2

Frequent Collaborators

7 joint publications

Yusuf Sert

5 joint publications

Mehmet Gümüş

4 joint publications

İrfan Çapan

2 joint publications

Yeliz Demir